Clinical and ethical concerns about switching patient treatment to "therapeutically interchangeable" medications.
Cohen
J S
JS
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D019091:Critical Pathways; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D004992:Ethics, Medical; D006356:Heartburn / Q000188:drug therapy*; D006801:Humans; D064747:Lansoprazole; D008329:Managed Care Programs; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010344:Patient Advocacy; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D064747:Lansoprazole; D009853:Omeprazole